Levosimendan in the Treatment of Patients with Severe Septic Cardiomyopathy

Levosimendan in the Treatment of Patients with Severe Septic Cardiomyopathy

(1) Background: The optimal treatment of septic cardiomyopathy (SCM) remains questionable. The aim of the study was to compare the treatment of SCM based on levosimendan versus the best available therapy. (2) Methods: We conducted an observational study including patients with severe septic cardiomy...

Full description

Bibliographic Details
Main Authors: Vasiliki Tsolaki, George E. Zakynthinos, John Papanikolaou, Vasileios Vazgiourakis, Kyriaki Parisi, George Fotakopoulos, Demosthenes Makris, Epaminondas Zakynthinos
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Life
Subjects:
circulatory shock
levosimendan
septic cardiomyopathy
survival
treatment
Online Access:https://www.mdpi.com/2075-1729/13/6/1346

Internet

https://www.mdpi.com/2075-1729/13/6/1346

Similar Items